26-05-2021 12:00
Equal access to medicines and therapies

WebEX platform and webstreaming
Equal access to medicine and therapies Equal access to medicine and therapies
Equal access to medicine and therapies © Adobe Stock

The Pharmaceutical Strategy for Europe adopted by the EC on 25/11/2020 is based on legislative and non-legislative action. It will create a future proof regulatory framework and support the industry in promoting research and technologies that actually reach patients. It will also take into account the weaknesses exposed by the coronavirus pandemic. In this context, the ENVI Health Working Group will bring together different external experts for exchanges of views.

It is estimated that approximately 2 billion people globally lack access to essential medicines. In some of the poorest countries this affects up to half of the population, and there is often a correlation between certain diseases e.g. tuberculosis and malaria and poverty. Development and marketing authorisation of medicines is risky and costly. In many low- and middle-income countries, and sometimes new medicines are too expensive even for the health systems of high-income countries. In the EU, Member States use a mix of policy instruments to regulate the prices and determine the reimbursement of medicines and therapies. Different policies are applied for different sectors, market segments and medicines.

There will also be opportunity to raise questions during a Q & A session.

We will use the WebEx platform. The ENVI Health Working Group webinar is open to public and will be webstreamed.